Longitudinal Association between Prostatitis and Development of Benign Prostatic Hyperplasia

Jennifer St. Sauver, Debra J. Jacobson, Michaela E. McGree, Cynthia J. Girman, Michael M. Lieber, Steven J. Jacobsen

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Objectives: To determine whether physician-diagnosed prostatitis was associated with later development of benign prostatic hyperplasia (BPH)-associated events in a longitudinal, population-based sample of 2447 men residing in Olmsted County, Minnesota. Methods: Medical records were reviewed for physician diagnosis of prostatitis and subsequent diagnoses of BPH, enlarged prostate, prostatism, and acute urinary retention. Records were also reviewed for medical or surgical treatments for BPH. Odds ratios were calculated to assess the associations between physician-diagnosed prostatitis and later development of development of BPH-associated events. Results: Physician-diagnosed prostatitis was associated with a 2.4-fold increased odds of receiving a later diagnosis of prostatism, enlarged prostate, or BPH (OR: 2.44, 95% CI: 1.48, 4.01). Prostatitis was also associated with a 70% increased odds of requiring later treatment for BPH (OR: 1.69, 95% CI: 1.28, 2.22), and a non-significant increased odds of acute urinary retention (OR: 1.33, 95% CI: 0.89, 1.99). Conclusions: Physician-diagnosed prostatitis was associated with an increased risk of later onset of several BPH-associated events. Physician-diagnosed prostatitis may therefore be an early marker or a risk factor for development of later prostatic or urologic problems.

Original languageEnglish (US)
Pages (from-to)475-479
Number of pages5
JournalUrology
Volume71
Issue number3
DOIs
StatePublished - Mar 2008

Fingerprint

Prostatitis
Prostatic Hyperplasia
Physicians
Prostatism
Urinary Retention
Prostate
Delayed Diagnosis
Medical Records
Odds Ratio
Therapeutics
Population

ASJC Scopus subject areas

  • Urology

Cite this

St. Sauver, J., Jacobson, D. J., McGree, M. E., Girman, C. J., Lieber, M. M., & Jacobsen, S. J. (2008). Longitudinal Association between Prostatitis and Development of Benign Prostatic Hyperplasia. Urology, 71(3), 475-479. https://doi.org/10.1016/j.urology.2007.11.155

Longitudinal Association between Prostatitis and Development of Benign Prostatic Hyperplasia. / St. Sauver, Jennifer; Jacobson, Debra J.; McGree, Michaela E.; Girman, Cynthia J.; Lieber, Michael M.; Jacobsen, Steven J.

In: Urology, Vol. 71, No. 3, 03.2008, p. 475-479.

Research output: Contribution to journalArticle

St. Sauver, J, Jacobson, DJ, McGree, ME, Girman, CJ, Lieber, MM & Jacobsen, SJ 2008, 'Longitudinal Association between Prostatitis and Development of Benign Prostatic Hyperplasia', Urology, vol. 71, no. 3, pp. 475-479. https://doi.org/10.1016/j.urology.2007.11.155
St. Sauver, Jennifer ; Jacobson, Debra J. ; McGree, Michaela E. ; Girman, Cynthia J. ; Lieber, Michael M. ; Jacobsen, Steven J. / Longitudinal Association between Prostatitis and Development of Benign Prostatic Hyperplasia. In: Urology. 2008 ; Vol. 71, No. 3. pp. 475-479.
@article{2ef49e74e43c40229575470900fdc27d,
title = "Longitudinal Association between Prostatitis and Development of Benign Prostatic Hyperplasia",
abstract = "Objectives: To determine whether physician-diagnosed prostatitis was associated with later development of benign prostatic hyperplasia (BPH)-associated events in a longitudinal, population-based sample of 2447 men residing in Olmsted County, Minnesota. Methods: Medical records were reviewed for physician diagnosis of prostatitis and subsequent diagnoses of BPH, enlarged prostate, prostatism, and acute urinary retention. Records were also reviewed for medical or surgical treatments for BPH. Odds ratios were calculated to assess the associations between physician-diagnosed prostatitis and later development of development of BPH-associated events. Results: Physician-diagnosed prostatitis was associated with a 2.4-fold increased odds of receiving a later diagnosis of prostatism, enlarged prostate, or BPH (OR: 2.44, 95{\%} CI: 1.48, 4.01). Prostatitis was also associated with a 70{\%} increased odds of requiring later treatment for BPH (OR: 1.69, 95{\%} CI: 1.28, 2.22), and a non-significant increased odds of acute urinary retention (OR: 1.33, 95{\%} CI: 0.89, 1.99). Conclusions: Physician-diagnosed prostatitis was associated with an increased risk of later onset of several BPH-associated events. Physician-diagnosed prostatitis may therefore be an early marker or a risk factor for development of later prostatic or urologic problems.",
author = "{St. Sauver}, Jennifer and Jacobson, {Debra J.} and McGree, {Michaela E.} and Girman, {Cynthia J.} and Lieber, {Michael M.} and Jacobsen, {Steven J.}",
year = "2008",
month = "3",
doi = "10.1016/j.urology.2007.11.155",
language = "English (US)",
volume = "71",
pages = "475--479",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Longitudinal Association between Prostatitis and Development of Benign Prostatic Hyperplasia

AU - St. Sauver, Jennifer

AU - Jacobson, Debra J.

AU - McGree, Michaela E.

AU - Girman, Cynthia J.

AU - Lieber, Michael M.

AU - Jacobsen, Steven J.

PY - 2008/3

Y1 - 2008/3

N2 - Objectives: To determine whether physician-diagnosed prostatitis was associated with later development of benign prostatic hyperplasia (BPH)-associated events in a longitudinal, population-based sample of 2447 men residing in Olmsted County, Minnesota. Methods: Medical records were reviewed for physician diagnosis of prostatitis and subsequent diagnoses of BPH, enlarged prostate, prostatism, and acute urinary retention. Records were also reviewed for medical or surgical treatments for BPH. Odds ratios were calculated to assess the associations between physician-diagnosed prostatitis and later development of development of BPH-associated events. Results: Physician-diagnosed prostatitis was associated with a 2.4-fold increased odds of receiving a later diagnosis of prostatism, enlarged prostate, or BPH (OR: 2.44, 95% CI: 1.48, 4.01). Prostatitis was also associated with a 70% increased odds of requiring later treatment for BPH (OR: 1.69, 95% CI: 1.28, 2.22), and a non-significant increased odds of acute urinary retention (OR: 1.33, 95% CI: 0.89, 1.99). Conclusions: Physician-diagnosed prostatitis was associated with an increased risk of later onset of several BPH-associated events. Physician-diagnosed prostatitis may therefore be an early marker or a risk factor for development of later prostatic or urologic problems.

AB - Objectives: To determine whether physician-diagnosed prostatitis was associated with later development of benign prostatic hyperplasia (BPH)-associated events in a longitudinal, population-based sample of 2447 men residing in Olmsted County, Minnesota. Methods: Medical records were reviewed for physician diagnosis of prostatitis and subsequent diagnoses of BPH, enlarged prostate, prostatism, and acute urinary retention. Records were also reviewed for medical or surgical treatments for BPH. Odds ratios were calculated to assess the associations between physician-diagnosed prostatitis and later development of development of BPH-associated events. Results: Physician-diagnosed prostatitis was associated with a 2.4-fold increased odds of receiving a later diagnosis of prostatism, enlarged prostate, or BPH (OR: 2.44, 95% CI: 1.48, 4.01). Prostatitis was also associated with a 70% increased odds of requiring later treatment for BPH (OR: 1.69, 95% CI: 1.28, 2.22), and a non-significant increased odds of acute urinary retention (OR: 1.33, 95% CI: 0.89, 1.99). Conclusions: Physician-diagnosed prostatitis was associated with an increased risk of later onset of several BPH-associated events. Physician-diagnosed prostatitis may therefore be an early marker or a risk factor for development of later prostatic or urologic problems.

UR - http://www.scopus.com/inward/record.url?scp=40749108948&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40749108948&partnerID=8YFLogxK

U2 - 10.1016/j.urology.2007.11.155

DO - 10.1016/j.urology.2007.11.155

M3 - Article

C2 - 18342190

AN - SCOPUS:40749108948

VL - 71

SP - 475

EP - 479

JO - Urology

JF - Urology

SN - 0090-4295

IS - 3

ER -